AARTISURF vs INDOAMIN: Stock Comparison
INDOAMIN is the larger company by market capitalisation. AARTISURF shows faster revenue growth and lower leverage, while INDOAMIN shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
AARTISURF leads 5; INDOAMIN leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | AARTISURF | INDOAMIN |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Specialty Chemicals | Specialty Chemicals |
Price
| Metric | AARTISURF | INDOAMIN |
|---|---|---|
| Live Price | ₹658.55 | ₹137.95 |
| Day Change | 1.97% | -1.75% |
| Volume | 1.04 L | 1.39 L |
| 52-Week High | ₹677.7 | ₹149 |
| 52-Week Low | ₹316 | ₹81.9 |
| Distance from 52W High | -2.83% | -7.42% |
Valuation
| Metric | AARTISURF | INDOAMIN |
|---|---|---|
| Market Cap | ₹431 Cr | ₹928 Cr |
| P/E Ratio | 28.84x | 11.47x |
| P/B Ratio | 2.17x | 2.37x |
| EPS | ₹10.63 | ₹4.22 |
| Book Value | ₹289.14 | ₹54.25 |
| Dividend Yield | 0.2% | 0.39% |
Growth
| Metric | AARTISURF | INDOAMIN |
|---|---|---|
| Revenue Growth (TTM YoY) | 26.8% | 11.3% |
| EPS Growth (TTM YoY) | -57% | 76% |
| Qtr Sales Growth | 0% | -1.96% |
| Qtr Profit Growth | -0.84% | -0.48% |
Profitability & Leverage
| Metric | AARTISURF | INDOAMIN |
|---|---|---|
| ROE | 5.14% | 20.14% |
| ROCE | 6.33% | 13.9% |
| Net Margin | 1.44% | 6.84% |
| Operating Margin | 3.48% | 11.2% |
| Debt to Equity | 0.42x | 0.79x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | AARTISURF | INDOAMIN |
|---|---|---|
| Promoter Holding | 49.63%▼ 0.03 pp | 58.42% |
| FII Holding | 0.08%▼ 0.06 pp | 0.08%▲ 0.06 pp |
| DII Holding | 0% | 0% |
| Public Holding | 50.07%▲ 0.09 pp | 41.5%▼ 0.06 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AARTISURF and INDOAMIN.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.